Thacker, Seth G <br/><br/>
CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis.  [electronic resource] 

 -  PLoS neglected tropical diseases  02 2020 
 - e0008050 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1935-2735 
<br/><br/><label>Standard No.: </label>10.1371/journal.pntd.0008050  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antimony--administration & dosage<br/>Cell Line<br/>Chemokines--genetics<br/>Female<br/>Gene Expression Regulation--drug effects<br/>Humans<br/>Leishmania major<br/>Leishmaniasis, Cutaneous--drug therapy<br/>Leukocytes, Mononuclear--drug effects<br/>Macaca fascicularis<br/>Male<br/>Oligodeoxyribonucleotides--administration & dosage